RAC 2.92% $1.94 race oncology ltd

Ann: Race releases complete cardio-protection data & video, page-82

  1. 6,744 Posts.
    lightbulb Created with Sketch. 1714
    I asked ChatGPT to summarise your bullet points and here it is:

    Bisantrene is a drug that binds to iron, which reduces iron-dependent functions that cause cardiotoxicity, without reducing the anti-cancer effects of oxidative stress. When used in high doses, it relies on its Anthracycline effects to kill cancer, and at low doses, it relies on its power as an FTO inhibitor. Reducing FTO expression can help stop the growth of cancer and increase the effectiveness of treatment. Bisantrene is an additive and synergistic drug when used in combination with other standard treatments.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.